DRI vs STRO
Darden Restaurants Inc (DRI) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DRI and STRO stock pages for the full models.
Not investment advice.